公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2017 | Aurora A and NF-κB survival pathway drive chemoresistance in acute myeloid leukemia via the TRAF-interacting protein TIFA | Wei T.-Y.W.; Wu P.-Y.; Wu T.-J.; HSIN-AN HOU ; WEN-CHIEN CHOU ; Teng C.-L.J.; Lin C.-R.; Chen J.-M.M.; Lin T.-Y.; Su H.-C.; Huang C.-C.F.; Yu C.-T.R.; Hsu S.-L.; HWEI-FANG TIEN ; Tsai M.-D. | Cancer Research | 38 | 33 | |
1986 | Autologous bone marrow transplantation after supralethal dose of total body irradiation in a case of mycosis fungoides | YONG-CHANG CHEN ; CHING-HUA WANG ; Huang, S C; Lee, E F; DONG-TSAMN LIN ; MING-CHING SHEN ; Liu, M C; HWEI-FANG TIEN ; Lin, K S | Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association | | | |
1990 | bcr Rearrangements in philadelphia chromosome-positive acute lymphoblastic leukemia. A study of five chinese patients in Taiwan | Lin M.-T.; HWEI-FANG TIEN ; Wang C.-H.; YAO-CHANG CHEN ; DONG-TSAMN LIN ; Lin K.-H. | Cancer Genetics and Cytogenetics | 5 | | |
2009 | Bone marrow angiogenesis magnetic resonance imaging in patients with acute myeloid leukemia: Peak enhancement ratio is an independent predictor for overall survival | TIFFANY TING-FANG SHIH ; HSIN-AN HOU ; Liu C.-Y.; BANG-BIN CHEN ; JIH-LUH TANG ; Chen H.-Y.; Wei S.-Y.; MING YAO ; SHANG-YI HUANG ; WEN-CHIEN CHOU ; SZU-CHUN HSU ; WOEI TSAY ; CHIH-WEI YU ; CHAO-YU HSU ; HWEI-FANG TIEN ; PAN-CHYR YANG | Blood | 70 | 60 | |
1989 | Bone marrow involvement in non-Hodgkin's lymphoma. | HONG-SHIEE LAI ; HWEI-FANG TIEN ; Hsieh H.C.; YAO-CHANG CHEN ; Su I.J.; Wang C.H.; Liu M.C.; ANN-LII CHENG ; MING-CHING SHEN ; Liu C.H. | Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association | 11 | 0 | |
2022 | Bone marrow plasma level of decorin may be associated with improved treatment outcomes in a subset of multiple myeloma patients | Huang, Shang-Yi; Lin, Hsiu-Hsia; MING YAO ; JIH-LUH TANG ; SHANG-JU WU ; WEN-CHIEN CHOU ; SZU-CHUN HSU ; BOR-SHENG KO ; HWEI-FANG TIEN | Journal of the Formosan Medical Association = Taiwan yi zhi | 1 | 0 | |
2016 | Cabozantinib is selectively cytotoxic in acute myeloid leukemia cells with FLT3-internal tandem duplication (FLT3-ITD) | Lu J.-W; Wang A.-N; Liao H.-A; Chen, Chien-Yuan ; HSIN-AN HOU ; CHUNG-YI HU ; HWEI-FANG TIEN ; DA-LIANG OU ; LIANG-IN LIN | Cancer Letters | 25 | 26 | |
2022 | Cabozantinib promotes erythroid differentiation in K562 erythroleukemia cells through global changes in gene expression and JNK activation | Fu, Yu-Hsuan; DA-LIANG OU ; Yang, Yi-Ru; Su, Kuan-Wei; Chen, Chien-Yuan ; HWEI-FANG TIEN ; Shen, Che-Kun James; Shen, Che-Kun James; Chien, Hsiung-Fei; LIANG-IN LIN | Cancer Gene Therapy | 2 | 1 | |
2014 | Calreticulin mutation was rarely detected in patients with myelodysplastic syndrome | HSIN-AN HOU ; Kuo Y.-Y.; WEN-CHIEN CHOU ; Chen P.-H.; HWEI-FANG TIEN | Leukemia | 7 | 7 | |
1998 | CD7 positive hematopoietic progenitors and acute myeloid leukemia and other minimally differentiated leukemia | HWEI-FANG TIEN ; Wang C.-H. | Leukemia and Lymphoma | 25 | 23 | |
2011 | CEBPA methylation as a prognostic biomarker in patients with de novo acute myeloid leukemia | Lin T.-C.; HSIN-AN HOU ; WEN-CHIEN CHOU ; DA-LIANG OU ; SUNG-LIANG YU ; HWEI-FANG TIEN ; LIANG-IN LIN | Leukemia | 39 | 37 | |
2022 | Cerebrospinal fluid soluble programmed death-ligand 1 is a useful prognostic biomarker in primary central nervous system lymphoma | Chieh-Lung Cheng ; CHI-YUAN YAO ; Huang, Po-Hao; CHIH-WEI YU ; Fang, Wei-Quan; Chuang, Wen-Hui; SHANG-JU WU ; YU-JEN LIN ; Hung, Yu-Chin; Tsai, Cheng-Hong; SHAN-CHI YU ; WEN-CHIEN CHOU ; HWEI-FANG TIEN | British journal of haematology | 0 | 0 | |
2010 | Changes in magnetic resonance bone marrow angiogenesis on day 7 after induction chemotherapy can predict outcome of acute myeloid leukemia | HSIN-AN HOU ; TIFFANY TING-FANG SHIH ; Liu C.-Y.; BANG-BIN CHEN ; JIH-LUH TANG ; MING YAO ; SHANG-YI HUANG ; WEN-CHIEN CHOU ; CHAO-YU HSU ; HWEI-FANG TIEN | Haematologica | 14 | 14 | |
1994 | Characteristic clinicopathologic features of adult B‐cell lymphoblastic lymphoma with special emphasis on differential diagnosis with an atypical form probably of blastic lymphocytic lymphoma of intermediate differentiation origin | ANN-LII CHENG ; Su I.‐J.; HWEI-FANG TIEN ; Wang C.‐C.; YAO-CHANG CHEN ; Wang C.‐H. | Cancer | 18 | | |
1993 | Characterization of acute myeloid leukemia (AML) coexpressing lymphoid markers: Different biologic features between T-cell antigen positive and B-cell antigen positive AML | HWEI-FANG TIEN ; Wang C.-H.; YAO-CHANG CHEN ; MING-CHING SHEN ; Lin D.-T.; KAI-HSIN LIN | Leukemia | 24 | 25 | |
2000 | Characterization of acute myeloid leukemia with MLL rearrangements - No increase in the incidence of coexpression of lymphoid-associated antigens on leukemic blasts | HWEI-FANG TIEN ; Hsiao C.-H.; JIH-LUH TANG ; WOEI TSAY ; Hu C.-H.; Kuo Y.-Y.; Wang C.-H.; YAO-CHANG CHEN ; MING-CHING SHEN ; Lin D.-T.; Lin K.-H.; Lin K.-S. | Leukemia | 13 | 11 | |
2008 | Characterization of acute myeloid leukemia with PTPN11 mutation: The mutation is closely associated with NPM1 mutation but inversely related to FLT3/ITD | HSIN-AN HOU ; WEN-CHIEN CHOU ; LIANG-IN LIN ; Chen, Chien-Yuan ; JIH-LUH TANG ; Tseng M.-H.; Huang C.-F.; Chiou R.-J.; Lee F.-Y.; Liu M.-C.; HWEI-FANG TIEN | Leukemia | 58 | 54 | |
2005 | Characterization of CEBPA mutations in acute myeloid leukemia: Most patients with CEBPA mutations have biallelic mutations and show a distinct immunophenotype of the leukemic cells | LIANG-IN LIN ; Chen, Chien-Yuan ; Lin D.-T.; WOEI TSAY ; JIH-LUH TANG ; Yeh Y.-C.; Shen H.-L.; Su F.-H.; MING YAO ; Huang S.-Y.; HWEI-FANG TIEN | Clinical Cancer Research | 183 | 178 | |
1992 | Characterization of Philadelphia-chromosome-positive acute leukemia by clinical, immunocytochemical, and gene analysis | HWEI-FANG TIEN ; Wang C.-H.; Chuang S.-M.; Lee F.-Y.; Liu M.-C.; YAO-CHANG CHEN ; MING-CHING SHEN ; Lin D.-T.; KAI-HSIN LIN ; Lin K.-S.; Liu C.-H. | Leukemia | 31 | 27 | |
1988 | Characterization of the spectrum of postthymic T‐cell malignancies in Taiwan a clinicopathologic study of HTLV‐1‐positive and HTLV‐1‐negative cases | Su I.-J.; Wang C.-H.; ANN-LII CHENG ; YAO-CHANG CHEN ; Hsieh H.-C.; HWEI-FANG TIEN ; Huang S.-S.; CHUNG-YI HU ; PEI-JER CHEN ; Chen J.-Y.; Hsu H.-C.; Chuang S.-M.; MING-CHING SHEN ; Kadin M.E. | Cancer | 45 | | |